Patents by Inventor Matthew COOPERBERG

Matthew COOPERBERG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DETERMINING RISK OF PROSTATE TUMOR AGGRESSIVENESS
    Publication number: 20210332441
    Abstract: This disclosure relates to methods, computer products, computer-implemented methods, and systems for predicting the probability or risk of prostate cancer recurrence and tumor aggressiveness in a patient. The method is based, in part, on the patient's risk profile that includes the presence/degree of specific copy number variations and predictive clinical factors. The methods and systems can be used to aid in treatment selection.
    Type: Application
    Filed: April 5, 2021
    Publication date: October 28, 2021
    Inventors: Pamela PARIS, Matthew COOPERBERG, Peter CARROLL
  • Determining risk of prostate tumor aggressiveness
    Patent number: 10968485
    Abstract: This disclosure relates to methods, computer products, computer-implemented methods, and systems for predicting the probability or risk of prostate cancer recurrence and tumor aggressiveness in a patient. The method is based, in part, on the patient's risk profile that includes the presence/degree of specific copy number variations and predictive clinical factors. The methods and systems can be used to aid in treatment selection.
    Type: Grant
    Filed: March 10, 2017
    Date of Patent: April 6, 2021
    Assignee: The Regents of the University of California
    Inventors: Pamela Paris, Matthew Cooperberg, Peter Carroll
  • DETERMINING RISK OF PROSTATE TUMOR AGGRESSIVENESS
    Publication number: 20170183744
    Abstract: This disclosure relates to methods, computer products, computer-implemented methods, and systems for predicting the probability or risk of prostate cancer recurrence and tumor aggressiveness in a patient. The method is based, in part, on the patient's risk profile that includes the presence/degree of specific copy number variations and predictive clinical factors. The methods and systems can be used to aid in treatment selection.
    Type: Application
    Filed: March 10, 2017
    Publication date: June 29, 2017
    Inventors: Pamela PARIS, Matthew COOPERBERG, Peter CARROLL